← Leaderboards
Laurence A Harker
Emory University
$3,935,114
Attributed
$3,935,114
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,935,114 · 6
By mechanism
M01$3,516,828 · 4
P51$418,286 · 2
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Sunil Singhal$10,554,167
- John S. Lollar$19,901,192
- John P Bilezikian$25,660,421
- Jeff M Sands$14,564,095
- Hans E Grossniklaus$6,161,558
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationRecombinant ProteinsPlateletsMegakaryocytesHemodialysisOutcomes ResearchHematopoiesisDosageBlood Disorder ChemotherapyBlood ChemistryCell Population StudyCellular PathologyFlow CytometryCardiovascular Disorder PreventionArtery OcclusionBone Marrow DisorderDiet TherapyBone MarrowDrug Administration RoutesDrug Screening /EvaluationAnticoagulantsDietary Lipid
Grant awards (14)
AV SHUNT IMPLANTATION IN HEMODIALYSIS PATIENTS$293,069
M01 · FY2002 · RR
PREVENTION OF GRAFT FAILURE BY DIETARY N 3 FATTY ACIDS$293,069
M01 · FY2002 · RR
PREVENTION OF GRAFT FAILURE BY DIETARY N 3 FATTY ACIDS$293,069
M01 · FY2002 · RR
AV SHUNT IMPLANTATION IN HEMODIALYSIS PATIENTS$293,069
M01 · FY2002 · RR
PLATELET PRODUCTION &DESTRUCTION$293,069
M01 · FY2002 · RR
PLATELET PRODUCTION &DESTRUCTION$293,069
M01 · FY2002 · RR
EFFECTS OF PEG RHUMGDF ON PLATELET LIFESPAN, PRODUCTION &FUNCTION$293,069
M01 · FY2002 · RR
EFFECTS OF PEG RHUMGDF ON PLATELET LIFESPAN, PRODUCTION &FUNCTION$293,069
M01 · FY2002 · RR
GENETICALLY ENHANCED ANGIOACCESS VASCULAR GRAFTS$209,143
P51 · FY2002 · RR
ENDARTERECTOMY PREVENTION OF THROMBOSIS &RESTENOSIS$209,143
P51 · FY2002 · RR
AV SHUNT IMPLANTATION IN HEMODIALYSIS PATIENTS$293,069
M01 · FY2001 · RR
EFFECTS OF PEG RHUMGDF ON PLATELET LIFESPAN, PRODUCTION &FUNCTION$293,069
M01 · FY2001 · RR
PLATELET PRODUCTION &DESTRUCTION$293,069
M01 · FY2001 · RR
PREVENTION OF GRAFT FAILURE BY DIETARY N 3 FATTY ACIDS$293,069
M01 · FY2001 · RR